Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Salmi

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
Cancer|March 26, 1999
Military service of male survivors of childhood malignanciesP M Lähteenmäki, H A Salmi, T T Salmi, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2016
Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosisTeea T Salmi, Kalle Kurppa, Kaisa Hervonen, et al.
Neuropathology and Applied Neurobiology|April 24, 1999
Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomasH Haapasalo, S Sallinen, P Sallinen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1990
A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre StudyM Perkkiö, L Hovi, J Rajantie, et al.
Maturitas|January 1, 1995
Can progestin be limited to every third month only in postmenopausal women taking estrogen?E Hirvonen, T Salmi, J Puolakka, et al.
Neuromuscular Disorders : NMD|April 24, 2017
Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1 mutations benefits from riboflavin therapyM Auranen, A Paetau, P Piirilä, et al.
Pediatric Blood & Cancer|January 31, 2004
Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusionJukka Kanerva, Ulla M Saarinen-Pihkala, Tarja Niini, et al.
Clinical Chemistry|April 28, 2001
Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of ageP Suominen, A Virtanen, M Lehtonen-Veromaa, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 3, 1998
Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levelsJ Toppari, A Kaipia, M Kaleva, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Cancer|March 26, 1999
Military service of male survivors of childhood malignanciesP M Lähteenmäki, H A Salmi, T T Salmi, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2016
Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosisTeea T Salmi, Kalle Kurppa, Kaisa Hervonen, et al.
Neuropathology and Applied Neurobiology|April 24, 1999
Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomasH Haapasalo, S Sallinen, P Sallinen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1990
A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre StudyM Perkkiö, L Hovi, J Rajantie, et al.
Maturitas|January 1, 1995
Can progestin be limited to every third month only in postmenopausal women taking estrogen?E Hirvonen, T Salmi, J Puolakka, et al.
Neuromuscular Disorders : NMD|April 24, 2017
Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1 mutations benefits from riboflavin therapyM Auranen, A Paetau, P Piirilä, et al.
Pediatric Blood & Cancer|January 31, 2004
Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusionJukka Kanerva, Ulla M Saarinen-Pihkala, Tarja Niini, et al.
Clinical Chemistry|April 28, 2001
Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of ageP Suominen, A Virtanen, M Lehtonen-Veromaa, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 3, 1998
Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levelsJ Toppari, A Kaipia, M Kaleva, et al.
Pageof 27